September 15, 2022 Rare Disease Workshop Highlights the Importance of Data Sharing in Drug Development C-Path, NORD and FDA hosted an annual workshop September 13-14 to spotlight the impact of their innovative data and analytics plat
September 14, 2022 C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases TUCSON, Ariz., Sept. 14, 2022 — Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Pat
September 13, 2022-September 14, 2022 View Now | 2022 RDCA-DAP Workshop, September 13-14 Since its launch in 2019, the Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) has established i
September 8, 2022 C-Path’s Kristen Swingle Named President Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-
September 7, 2022 Evaluating the Use of Backup Solutions for ePRO Systems has been published in Applied Clinical Trials
September 1, 2022 Drug Development for Cystic Kidney Diseases Inherited cystic diseases include a spectrum of disorders, such as autosomal dominant polycystic kidney disease (ADPKD), autosomal
September 1, 2022 C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Lysosomal Diseases TUCSON, Ariz., Sept. 1, 2022 — Critical Path Institute (C-Path) today announced the launch of a pre-consortium collaboration foc
August 26, 2022 Four PKD Reports Published in CJASN C-Path and PKDOC are excited to announce that four reports summarizing Sessions 1, 2, and 3B from the 2021 PKD Regulatory Summit h
August 25, 2022 Upcoming Rare Disease Workshop Focuses on the Importance of Data Sharing in Drug Development C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platfo
August 24, 2022 Oak Hill Bio Joins C-Path’s International Neonatal Consortium TUCSON, Ariz., Aug. 24, 2022 — Critical Path Institute (C-Path) today announced that Oak Hill Bio (Oak Hill), a clinical-stage n
